Bluetongue serotype 3 (BTV-3) vaccination
Information on BTV-3 vaccines for keepers and vets, including rules for reporting vaccinations and keeping records.
You must report your use of the BTV-3 vaccine. It is against the law to use the vaccine without reporting it.
There are 3bluetongue serotype (BTV-3)vaccines authorised for use in the UK:
- Bluevac-3
- մհ3
- Syvazul BTV 3
Guidance for keepers
Deciding whether to vaccinate
Work with your vet to determine ifbluetongue vaccination is right for your animals.
You can also check the for more information ondeciding whether to vaccinate your animals.
Administering vaccines
Avet must prescribe BTV-3 vaccines.
As the animal keeper, you can administer the vaccine to your animals.
You shoulduse safe practice, based on the code of practice on the responsible use of animal medicines on the farm.
Reporting vaccinations and keeping records
In England, Wales and Scotland you must:
- keep a record of every animal you vaccinate – the information you need to record ison thegeneral licencefor England, or
- keep these records for at least 5 years
- report vaccinations within 48 hours – providing details including the individual animal IDs and vaccine you use
In Northern Ireland you must:
- within 5 working days of vaccinating
Guidance for vets
The UK, Wales, Scotland and Northern Ireland Chief Veterinary Officers ask all vets to record BTV-3 vaccine use and inform relevant authorities of any adverse effects.
Veterinarians should read the relevant advisory note for their country before prescribing any BTV-3 vԱ.
Read the:
Vets in England, Scotland and Wales should notify Defra within 7 days of prescribing the vaccine using theprescription of theBTV-3vaccine reporting form.
Vets in Northern Ireland shouldand return the completed record to their local DAERA Direct Office.
Market authorisation
Marketing authorisations for BTV-3 vaccines(Bluevac-3, մհ3 and Syvazul)have been granted for use in Great Britain and Northern Ireland.
Transition period for unauthorised vaccines
Unauthorised vaccines that were imported under permit before October 2025 into Great Britain (31 December 2025 for Northern Ireland) can continue to be used, providing:
a)the licenceor declarationconditions are met
b)thevaccine has not exceededitsexpiry date
c)thevaccine waspurchasedon the Great BritainorNorthern Ireland markets
Bluevac-3 suspension for injection for sheep and cattle
The marketing authorisation for the Bluevac-3 vaccine is held by CZ Veterinaria S.A. Ithas marketing authorisations for use in Great Britain and Northern Ireland.
This vaccineisfor the active immunisation of:
- sheep - to reduce the viraemia, mortality and clinical signs caused by the serotype 3 of the bluetongue virus
- cattle - to reduce the viraemia against the serotype 3 of the bluetongue virus
Find the summary of product characteristics (SPC) for the authorised Bluevac-3 product:
- forGreat Britain-on the VMD’s Product Information Database (PID)
- for Northern Ireland-on the
Find information on unauthorisedBluevac-3vaccine that was imported under permit before October 2025 into Great Britain (31 December 2025 for Northern Ireland):
- summary of product characteristics for Bluevac-3 BTV-3 vaccine in the UK
- permit for use of Bluevac-3 bluetongue serotype 3 vaccine in the UK
մհ3 suspension for injection for sheep and cattle
The marketing authorisation for the մհ3 vaccine is held by Boehringer Ingelheim Animal Health UK Limited.It has marketing authorisations for use in Great Britain and Northern Ireland.
This vaccine is for the active immunisation of:
- sheep - to reduce viraemia and to prevent clinical signs caused by BTV-3
- cattle - to prevent viraemia and to prevent clinical signs caused by BTV-3
Find the summary of product characteristics (SPC) for the authorised մհ3 product on the VMD’s Product Information Database (PID).
Find information on unauthorisedBULTAVO 3vaccine that was imported under permit before October 2025 into Great Britain (31 December 2025 for Northern Ireland):
- summary of product characteristics forմհ3 vaccine in the UK
- permit for use of մհ3 vaccine vaccine in the UK
Syvazul - BTV 3 suspension for injection for sheep and cattle
The marketing authorisation for the Syvazul vaccine is held by Laboratorios SYVA S.A.U.Ithas marketing authorisations for use in Great Britain and Northern Ireland.
This vaccine is for the active immunisation of:
- sheep - to reduce viraemia, mortality, clinical signs and lesions caused by bluetongue serotype 3
- cattle - to reduce viraemia caused by bluetongue virus serotype 3
Find the summary of product characteristics (SPC) for theauthorisedSyvazulBTV 3 product:
- for Great Britain -on the VMD’s Product Information Database
- for Northern Ireland -on the
Find information on unauthorisedSyvazulBTV 3vaccine that was imported under permit before October 2025 into Great Britain (31 December 2025 for Northern Ireland):
- summary of product characteristics forSyvazulBTV 3 vaccine in the UK
- permit for use ofSyvazulBTV 3 bluetongue serotype 3 vaccine in the UK
Bluetongue testing
You should not test vaccinated animalswithin7 days ofvaccination. Anysample takenless than 7 daysafter vaccinationcould lead to false positive results.
Read more about bluetongue testing.
Updates to this page
-
We've moved some guidance from other ǸԹ pages onto this page.
-
You can use these vaccines in Northern Ireland: updated guidance to include the rules you must follow.
-
Information has been updated about the transition period for permitted vaccines. Unauthorised BTV-3 vaccines permitted for use subject to licence or declaration can be imported in Northern Ireland under a permit until 31 December 2025. They can continue to be used under permit until they reach their expiry date, as long as they were purchased on the Great Britain and Northern Ireland markets.
-
First published.